{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-23-000124","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.892100+00:00","generated_at":"2026-06-09T07:03:26.720243+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Health Catalyst beats Q3 rev midpoint; raises FY rev guidance; Adj. EBITDA positive","bullets":["Total revenue $73.8M (+8% YoY); tech revenue $46.0M (+4%), pro services $27.8M (+14%).","Net loss $22.0M vs $45.7M loss YoY (improved 52%); loss from ops $24.6M vs $45.7M.","Adjusted EBITDA $2.0M vs ($4.6M) loss a year ago; Q3 beat midpoint on both rev and EBITDA.","Raised FY2023 revenue guidance range; reiterated FY2023 Adjusted EBITDA guidance.","Full Q3 results and conference call rescheduled to November 2, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-23-000124","json":"https://secwatch.observer/filing/0001636422-23-000124.json","markdown":"https://secwatch.observer/filing/0001636422-23-000124.md","text":"https://secwatch.observer/filing/0001636422-23-000124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/0001636422-23-000124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/hcat-20231027.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T07:03:26.720243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7bfe31c657382a1dccae4ceb71be4425f8d043a6","claim":"Health Catalyst, Inc. reported the quarter ended September 30, 2023 results: revenue $73.8 million. Guidance raised.","evidence_excerpt":"timing. See below for quarterly conference call details. “For the third quarter of 2023, I am pleased by our strong preliminary financial results, including total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, with these results beating the mid-point of our quarterly guidance on each metric. Additionally, we are grateful to be in a position to raise","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000124/0001636422-23-000124-index.htm","confidence":0.87,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$73.8 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}